Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Oct 30, 2023

BUY
$102.5 - $123.59 $11 Million - $13.3 Million
107,800 New
107,800 $13.1 Million
Q4 2022

Feb 23, 2023

BUY
$100.86 - $132.13 $292,494 - $383,177
2,900 New
2,900 $376 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Portman Square Capital LLP Portfolio

Follow Portman Square Capital LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portman Square Capital LLP, based on Form 13F filings with the SEC.

News

Stay updated on Portman Square Capital LLP with notifications on news.